Cargando…

The Usefulness of Biological and Neuroimaging Markers for the Diagnosis of Early-Onset Alzheimer's Disease

The recent proposed criteria for Alzheimer's Disease (AD) have strongly claimed the usefulness of biological and neuroimaging markers for early identification AD. Cerebrospinal fluid (CSF) Tau/Abeta ratio, hippocampal atrophy, posterior cingulate, and neocortical associative area hypometabolism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padovani, Alessandro, Gilberti, Nicola, Borroni, Barbara
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087487/ https://www.ncbi.nlm.nih.gov/pubmed/21559247 http://dx.doi.org/10.4061/2011/296374

Ejemplares similares

Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin
por: Borroni, Barbara, et al.
Publicado: (2018)

Clinical, Biological, and Imaging Features of Monogenic Alzheimer's Disease
por: Pilotto, Andrea, et al.
Publicado: (2013)

Artificial neural networks allow the use of simultaneous measurements of Alzheimer Disease markers for early detection of the disease
por: Di Luca, Monica, et al.
Publicado: (2005)

Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC
por: Benussi, Alberto, et al.
Publicado: (2018)

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
por: Veitch, Dallas P., et al.
Publicado: (2021)

Neuroimaging in Alzheimer's Disease for Early Diagnosis: A Comprehensive Review
por: Aramadaka, Saikumar, et al.
Publicado: (2023)

Herpes simplex virus, early neuroimaging markers and incidence of Alzheimer’s disease
por: Linard, Morgane, et al.
Publicado: (2021)

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
por: Sala, Arianna, et al.
Publicado: (2021)

Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
por: Falgàs, Neus, et al.
Publicado: (2020)

Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease
por: Wollman, Daniel E., et al.
Publicado: (2003)

Multimodal Neuroimaging in Alzheimer’s Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle
por: Chételat, Gaël
Publicado: (2018)

The Early Diagnosis of Alzheimer’s Disease: A Patient-Centred Conversation with the Care Team
por: Nasreddine, Ziad, et al.
Publicado: (2022)

An Intelligent System for Early Recognition of Alzheimer’s Disease Using Neuroimaging
por: Odusami, Modupe, et al.
Publicado: (2022)

Neuroimaging Modalities in Alzheimer’s Disease: Diagnosis and Clinical Features
por: Kim, JunHyun, et al.
Publicado: (2022)

Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?
por: Mirkin, Sophia, et al.
Publicado: (2023)

Neuroimaging in the early diagnosis of neurodegenerative disease
por: Stoessl, A Jon
Publicado: (2012)

Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields
por: Premi, Enrico, et al.
Publicado: (2018)

Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
por: Zimmer, Jennifer A., et al.
Publicado: (2021)

Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease
por: Zeng, Hong-Mei, et al.
Publicado: (2020)

Neuroimaging markers of global cognition in early Alzheimer's disease: A magnetic resonance imaging–electroencephalography study
por: Waser, Markus, et al.
Publicado: (2018)

Detection of Alzheimer’s disease onset using MRI and PET neuroimaging: longitudinal data analysis and machine learning
por: Aberathne, Iroshan, et al.
Publicado: (2023)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

Citicoline Treatment in Acute Ischemic Stroke: A Randomized, Single-Blind TMS Study
por: Premi, Enrico, et al.
Publicado: (2022)

Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
por: Ikeda, Masaki, et al.
Publicado: (2021)

Neuroimaging Markers for Determining Former American Football Players at Risk for Alzheimer's Disease
por: Baragi, Vijaykumar M., et al.
Publicado: (2022)

Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009)

Presumed small vessel disease, imaging and cognition markers in the Alzheimer’s Disease Neuroimaging Initiative
por: Fiford, Cassidy M, et al.
Publicado: (2021)

NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
por: Almodóvar-Payá, Carmen, et al.
Publicado: (2022)

Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
por: Barnes, Josephine, et al.
Publicado: (2013)

Linguistic markers predict onset of Alzheimer's disease
por: Eyigoz, Elif, et al.
Publicado: (2020)

Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration
por: Benussi, Alberto, et al.
Publicado: (2022)

Conventional machine learning and deep learning in Alzheimer's disease diagnosis using neuroimaging: A review
por: Zhao, Zhen, et al.
Publicado: (2023)

Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease
por: Fornari, Chiara, et al.
Publicado: (2022)

Neuroimaging Measures as Endophenotypes in Alzheimer's Disease
por: Braskie, Meredith N., et al.
Publicado: (2011)

Neuroimaging of Mouse Models of Alzheimer’s Disease
por: Jullienne, Amandine, et al.
Publicado: (2022)

Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
por: De Roeck, Arne, et al.
Publicado: (2017)

Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer’s disease
por: Adewale, Quadri, et al.
Publicado: (2021)

Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices
por: Cai, Kunpeng, et al.
Publicado: (2017)

Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges
por: Dubois, Bruno, et al.
Publicado: (2015)

Pushing the Boundaries of Psychiatric Neuroimaging to Ground Diagnosis in Biology
por: Saggar, Manish, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qd4m8u393c31i4bgl3fmgckn0b